Spectranetics Announces Debt Financing

Go back to Spectranetics Announces Debt Financing

Spectranetics (SPNC) Submits FDA Premarket Notification 510(k) for Bridge Occlusion Balloon

December 9, 2015 6:29 AM EST

The Spectranetics Corporation (NASDAQ: SPNC) announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) submission of the Bridge Occlusion Balloon. Building on the long-standing clinical success and proven procedural safety of cardiac lead extraction, the... More